An observational study in Cholecystitis, Cholecystitis, Chronic and Chronic Calculous Cholecystitis, sponsored by Cision Vision, Inc.. Enrolling by invitation at 6 sites in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-08-04.
Sponsored by Cision Vision, Inc. · Observational
The goal of this observational study is to perform an in-human assessment of an investigational shortwave infrared (SWIR) imaging device, aimed to enhance the visualization of critical anatomical structures during surgical procedures in non-vulnerable adults between the ages of 18 and 70+. The main questions are to 1) evaluate the feasibility of utilizing SWIR imaging technology within a clinical environment, 2) ascertain the safety of the device, ensuring that its application does not interfere with or alter the established standard of care, and (3) collect preliminary human data that will inform and support the design of future research investigations.
It is not the goal of this study to deviate from the standard of care, nor will it influence the diagnostic or therapeutic decisions made by the clinical team.
The central hypothesis of this study is that shortwave infrared (SWIR) imaging will effectively visualize critical anatomical structures, such as nerves, ureters, and bile ducts, in human subjects. This expectation is grounded in favorable preclinical results observed in porcine models and cadaveric studies. Additionally, the investigators aim to demonstrate that the use of SWIR imaging can be accomplished without introducing additional risks to patients or disrupting established surgical workflows.
After study subjects have consented, the participating surgeons will use the imaging device to visualize key structure seen during the procedure for no more than 10 minutes per case. The surgeons are also asked to complete a device assessment for each case.
192 studies on the registry are indexed under Cholecystitis; 36 are open to participants now.
This study's planned enrollment of 50 is below the median of 222 across 55 observational studies indexed under Cholecystitis.
Browse Cholecystitis studies →This is the only study on the registry with Cision Vision, Inc. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Adult patients, excluding vulnerable populations, undergoing surgeries who are able to provide voluntary, informed consent.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Non-vulnerable adults
Exclusion Criteria:
Vulnerable adults who are not able to provide voluntary, .
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Non-vulnerable adults (ages 18+)
Device: Observational study of SWIR imaging device in surgery
SWIR surgical imaging device to help surgeons visualize key structures during procedures
Type of structures identified
Anatomic structures seen through the device during surgery
Time frame: May 29, 2026 to October 11, 2026
Qualitative assessment of device functionality and performance by surgeons
These qualitative measures include the ease of use, visualization performance, and the perceived change in their confidence level in their decision-making process.
Time frame: May 29, 2026 to October 11, 2026
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.